🎥 A MedTech Leader With a Healthy Outlook

40% gains in a heartbeat [Total Wealth] BROUGHT TO YOU BY MANWARD PRESS Dealmaker's Diary: A MedTech Leader With a Healthy Outlook SPONSORED [Ex- Wall Street Trader Urges: "Make ONE Move Before Upcoming Earnings"]( [Ex-Wall Street Trader]( Multi-Millionaire Pro-Trader Reveals #1 Earnings Trade Wall Street Has Been Hiding From Everyday Investors... See Why Most People Miss Out On Top Overnight Earnings Gains like +124%, +189% & +293% [>> Click Here To Reveal His Trading Trick <<]( [Alpesh Patel] Alpesh Patel Quantitative Investing Specialist The best companies don't miss a beat. They soldier on... staying consistent... and finding new ways to strengthen or improve their businesses. And the company that came up on my proprietary GVI system this week doesn't miss a beat... a heartbeat, that is. This medtech is a leading producer of medical devices and equipment for heart patients. SPONSORED [The "Inverted Real Estate Play" Wall Street Is Hiding From You!]( [Wall St For Rent]( Real estate is the greatest wealth generator in history. In fact, it's responsible for more millionaires than all other assets classes combined. But get this: Real estate crashes can create even bigger, faster fortunes than owning property can. For example, in 2008, John Paulson made $20 billion shorting the housing market. In 2020, Carl Icahn made $1.3 billion shorting shopping malls. Today, the $21 trillion commercial real estate market is in free fall. Pros have already played it for $600 million in a single day. [And the biggest trades are setting up now...]( Its sales are projected to grow to $6.6 billion. Profits are also growing at a steady 15% per year... and the company makes a decent return on the capital it invests. And the stock's momentum has started to pick up. Based on my projections... there's a shot at 40% gains here in a year. I'll take it. Get all the details on the company - including the ticker - in my latest video. [Click here]( or on the image below to watch it. And if you have a stock you'd like me to run through my GVI system, send the ticker to [mailbag@manwardpress.com](mailto:mailbag@manwardpress.com?subject=Dealmaker%27s%20Diary). [Video - Bank on This Cheap Fintech That's Growing Quickly]( [WATCH THE VIDEO (WITH TRANSCRIPT)]( Happy hunting, Alpesh SPONSORED [Former CBOE Legend Speaks Out]( [Former CBOE Legend Speaks Out]( How to "Trick" Wall Street Into Paying You... Whether a Stock Goes UP Or DOWN Investors Have Seen overnight Gains As High As 124%... +189%... Even +293%! [Discover This Earnings "Trick" Here]( Alpesh Patel Alpesh Patel is an award-winning hedge fund and private equity fund manager, international bestselling author, and entrepreneur. He is the founder and CEO of Praefinium Partners, a Financial Times top FTSE 100 forecaster, and a senior Dealmaker in the U.K.'s Department for International Trade. As a recognized authority on fintech, online trading and venture capital, his past and current client list includes American Express, Merrill Lynch HSBC, Charles Schwab, Goldman Sachs, Barclays... and more. You are receiving this email because you subscribed to Total Wealth. To unsubscribe from Total Wealth, [click here](. Need help with your account? [Click here](. Have a question or comment for the editor? [Click here](mailto:mailbag@manwardpress.com). Please do not reply to this email as it goes to an unmonitored inbox. To cancel by mail or for any other subscription issues, write us at: Manward Press | Attn: Member Services | [14 West Mount Vernon Place | Baltimore, MD 21201](#) North America: [1.800.682.5210](#) | International: [+1.443.353.4263](#) Website: [manwardpress.com]( Keep the emails you value from falling into your spam folder. [Whitelist Total Wealth](. © 2024 Manward Press, LLC | All Rights Reserved Nothing published by Manward Press, LLC should be considered personalized investment advice. Although our employees may answer your general customer service questions, they are not licensed under securities laws to address your particular investment situation. No communication by our employees to you should be deemed personalized investment advice. We allow the editors of our publications to recommend securities that they own themselves. However, our policy prohibits editors from exiting a personal trade while the recommendation to subscribers is open. In no circumstance may an editor sell a security before subscribers have a fair opportunity to exit. The length of time an editor must wait after subscribers have been advised to exit a play depends on the type of publication. All other employees and agents must wait 24 hours after publication before trading on a recommendation. Any investments recommended by Manward Press, LLC should be made only after consulting with your investment advisor and only after reviewing the prospectus or financial statements of the company. Protected by copyright laws of the United States and international treaties. The information found on this website may only be used pursuant to the membership or subscription agreement and any reproduction, copying or redistribution (electronic or otherwise, including on the world wide web), in whole or in part, is strictly prohibited without the express written permission of Manward Press, LLC, 14 West Mount Vernon Place, Baltimore, MD 21201.